Europe PMCopen access
Estimating clinical and economic impacts and cost-effectiveness of introducing 20-valent pneumococcal conjugate vaccine in Taiwan's pediatric National Immunization Program and impacts of a delayed implementation
Taiwan, Cost-effectiveness Analysis, Pneumococcal Disease, 13-Valent Pneumococcal Conjugate Vaccine, 15-Valent Pneumococcal Conjugate Vaccine, 20-Valent Pneumococcal Conjugate Vaccine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 642294
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.